About ClinRM
Sponsor-side safety judgment, built for emerging biotech.
Effective safety management starts with sound clinical judgment, not a compliance checklist. Our physician executives evaluate risk pragmatically, on the sponsor’s side of the table, so every decision protects patients and keeps the program moving.
Why ClinRM
The safety function a clinical-stage company cannot yet justify hiring.
The name is the mandate: ClinRM stands for Clinical Risk Management — owning what a safety finding means for patients and for the program, not only whether it was filed on time.
Most pre-IND and Phase 1 biotechs have a capable CRO running case processing and no one on the sponsor side who owns the medical judgment behind it. That responsibility does not disappear — it lands on a CMO already carrying clinical, regulatory, and manufacturing.
ClinRM fills that seat. Senior safety physicians who have chaired safety committees, defended reportability decisions to FDA and EMA, and built PV systems that passed inspection — engaged at the size your program actually needs, and structured to step back the day you hire your own safety leader. What that hire inherits is deliberate: governance, SOPs, and safety records built for inspection from day one — a clean handover, not a cleanup.
Physician-led
Every engagement is supervised by a qualified MD. Safety scientists support the work; physicians own the judgment.
One team with your CRO
We never compete for operational scope. Clear interfaces, defined decision rights, and documented oversight.
Right-sized
A full safety bench or a single expert. Scale up through the program, and scale down when your hire arrives.
Global from day one
Global coverage with an EU QPPV on the bench, plus multilingual support across major markets.
Who we support
Built for emerging and growing organizations
ClinRM partners with sponsors that have a CRO for safety operations, but no in-house safety leader.
Pre-IND and early-phase biotechs
Preparing a first IND, or running first-in-human studies without a dedicated safety function.
Emerging biopharma
Two or three assets in the clinic and a safety workload that has outgrown improvisation.
CMOs without a safety leader
Carrying patient safety on top of clinical development, regulatory strategy, and CMC.
Investors and acquirers
Needing a physician-reviewed read on a target’s safety profile, signal history, and regulatory exposure.
Therapeutic experience
Hands-on clinical and regulatory experience grounded in real development challenges, not a capability matrix.
Global reach
Sponsors are supported wherever the program runs. Multilingual coverage across major markets: English, French, Spanish, Italian, Dutch.
We give the answer we would defend in an inspection, not the answer that is easiest to hear.Integrity · Transparency · Patient-centered
Core values
What drives every engagement
Integrity
Honest, evidence-based guidance — including when it is not what the sponsor wants to hear. Trust is built on transparency, not on agreeable answers.
Transparency
Open, direct communication at every stage, so you always understand the rationale behind a recommendation — and can defend it yourself.
Patient-centered
Patient safety is not negotiable. Every recommendation is guided by one principle: protecting the people your therapy is designed to help.
Ready to partner with ClinRM?
Tell us where the program stands. If we are not the right fit, we will say so on the first call.